Product image of Methyldopa supplied by GNH India

Methyldopa

Active Ingredient:
Methyldopa
Origin:
EU

Methyldopa

Methyldopa, the active ingredient in this product, is an alpha‑2 adrenergic agonist presented as an oral formulation for systemic use. It is employed to lower high blood pressure, including hypertension during pregnancy, by reducing sympathetic nervous system activity.

GNH India supplies this product as a licensed, GDP‑compliant international pharmaceutical supplier, adhering to stringent quality standards and regulatory requirements. The company provides reliable sourcing to hospitals, pharmacies and clinics worldwide, supporting consistent access to essential antihypertensive therapy across diverse markets globally.

Manufacturer / TM Owner

Waymade Plc

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Methyldopa is used to manage high‑blood‑pressure disorders by acting on central sympathetic pathways.

  • Essential hypertension: reduces systolic and diastolic pressure in patients with primary high blood pressure.
  • Secondary hypertension: assists in controlling blood pressure when caused by underlying conditions.
  • Gestational hypertension: helps maintain safe maternal blood pressure levels during pregnancy.

How It Works

  • After oral absorption, methyldopa is converted to alpha‑methyldopamine, which stimulates central alpha‑2 adrenergic receptors in the medulla. This activation decreases sympathetic outflow, leading to reduced norepinephrine release, lower peripheral vascular resistance, and ultimately a decline in arterial blood pressure.

Side Effects

Methyldopa may cause a range of adverse reactions, which vary in frequency and severity.

Common Side Effects

  • Dizziness: sensation of light‑headedness, especially upon standing.
  • Headache: mild to moderate pain in the head region.
  • Fatigue: persistent tiredness or lack of energy.
  • Dry mouth: reduced salivation causing oral discomfort.
  • Nasal congestion: blockage or stuffiness of the nasal passages.
  • Sedation: feeling unusually sleepy or sluggish.

Serious or Rare Side Effects

  • Hepatic dysfunction: signs of liver injury such as jaundice.
  • Hemolytic anemia: destruction of red blood cells leading to fatigue and pallor.
  • Severe hypotension: dangerously low blood pressure causing fainting.
  • Stevens‑Johnson syndrome: severe skin reaction with blistering.
  • Agranulocytosis: marked decrease in white blood cells, increasing infection risk.

Precautions & Warnings

When prescribing methyldopa, clinicians should consider several safety measures.

  • Blood pressure monitoring: regularly assess to avoid excessive hypotension.
  • Liver function: evaluate hepatic enzymes before and during therapy.
  • Discontinuation: taper the dose gradually to prevent rebound hypertension.
  • Pheochromocytoma: avoid use in patients with catecholamine‑secreting tumors.
  • Depression: monitor for mood changes, as central agents may affect mental state.
  • Store at ambient temperature: keep below 25 °C in the original packaging, protect from moisture.

Avoid Interactions

Methyldopa can interact with other medicines, influencing its efficacy or safety.

Major Interactions (Avoid)

  • MAO inhibitors: risk of severe hypertension when combined.
  • Sympathomimetic agents: may counteract the antihypertensive effect.
  • Other central α‑2 agonists: additive hypotensive response.

Moderate Interactions (Monitor Closely):\n- Diuretics: enhanced blood‑pressure lowering, requiring dose adjustment.

  • β‑blockers: potential for additive hypotension and bradycardia.
  • Lithium: possible increase in lithium levels, necessitating monitoring.

Frequently Asked Questions

Methyldopa is prescribed primarily for managing hypertension, including essential and secondary high blood pressure, as well as gestational hypertension that occurs during pregnancy. It works by lowering systemic vascular resistance through central nervous system mechanisms.

After oral intake, methyldopa is metabolized to alpha‑methyldopamine, which activates central alpha‑2 adrenergic receptors. This activation reduces sympathetic outflow, decreasing norepinephrine release and leading to lower peripheral vascular resistance and blood pressure.

The appropriate dose of methyldopa is determined by the prescribing healthcare professional based on the individual’s medical condition, response to therapy, and other factors. Patients should follow the dosage instructions provided by their prescriber.

Methyldopa is one of the few antihypertensives considered relatively safe for use in pregnancy, particularly for gestational hypertension. However, its safety in breastfeeding is not well established, and the decision to use it should be made by a qualified clinician.

To request methyldopa, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Methyldopa is a central‑acting alpha‑2 agonist, differing from diuretics, ACE inhibitors, or calcium‑channel blockers that act peripherally. It is especially useful in pregnancy because many other antihypertensives are contraindicated, but it may have a slower onset and distinct side‑effect profile.

Methyldopa should be stored at ambient temperature, preferably below 25 °C, in its original container to protect it from moisture and light. Keeping the product in a dry, cool place helps maintain its stability and potency.

Methyldopa is taken orally, usually in tablet form, with or without food as directed by a healthcare professional. The exact administration schedule, including timing and whether to take it with meals, should follow the prescriber’s guidance.

Serious risks include severe hypotension, liver dysfunction, hemolytic anemia, and rare skin reactions such as Stevens‑Johnson syndrome. Patients should be monitored for signs of these conditions and seek immediate medical attention if they occur.

Methyldopa is contraindicated in patients with known hypersensitivity to the drug, those with pheochromocytoma, or individuals taking monoamine oxidase inhibitors. Caution is also advised for patients with significant liver disease or a history of severe depression.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Methyldopa

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT